default author photo

Michael S. Avumegah

University of Queensland - School of Chemistry and Molecular Biosciences

St. Lucia

Brisbane

Australia

Coalition for Epidemic Preparedness Innovations

SCHOLARLY PAPERS

3

DOWNLOADS

504

TOTAL CITATIONS

4

Scholarly Papers (3)

1.

First Report of a Phase 1 Randomised Trial of Molecular Clamp-Stabilised Spike Protein-Based and MF59-Adjuvanted Vaccine for SARS-CoV-2

Number of pages: 37 Posted: 01 Feb 2021
University of Queensland - School of Chemistry and Molecular Biosciences, University of Melbourne - Department of Microbiology and Immunology (DMI), Australian National University (ANU) - Department of Immunology and Infectious Disease, University of Queensland - School of Chemistry and Molecular Biosciences, Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland, University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), Tanawell Consulting, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Queensland - TetraQ, University of Queensland - TetraQ, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, Burnet Institute, Burnet Institute, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), Australian National University (ANU) - Department of Immunology and Infectious Disease, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, University of Queensland - Institute for Molecular Bioscience, University of Queensland - School of Chemistry and Molecular Biosciences and University of Queensland - School of Chemistry and Molecular Biosciences
Downloads 414 (176,035)
Citation 2

Abstract:

Loading...

2.

Rapid Application of the Molecular Clamp Platform for SARS-CoV-2

Number of pages: 65 Posted: 24 Nov 2020
University of Queensland - Institute for Molecular Bioscience, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Melbourne - Department of Microbiology and Immunology (DMI), Australian National University (ANU) - Department of Immunology and Infectious Disease, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, Viroclinics Xplore, Viroclinics Xplore, Viroclinics Xplore, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland - Australian Institute for Bioengineering and Nanotechnology (AIBN), CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, CSIRO Manufacturing, University of Queensland - TetraQ, StageBio, University of Queensland - Centre for Advanced Materials Processing and Manufacturing, University of Queensland - TetraQ, University of Queensland - TetraQ, University of Melbourne - Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity - WHO Collaborating Centre for Reference and Research on Influenza, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - Australian Infectious Diseases Research Centre, Utrecht University - Division of Pathology, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, Australian National University (ANU) - Department of Immunology and Infectious Disease, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, University of Queensland - School of Chemistry and Molecular Biosciences, University of Queensland - School of Chemistry and Molecular Biosciences and University of Queensland - School of Chemistry and Molecular Biosciences
Downloads 57 (989,921)
Citation 2

Abstract:

Loading...

SARS-CoV-2, Molecular Clamp, subunit vaccine, rapid response, hamster protection, neutralising antibodies, polyfunctional T cells, cytotoxic CD8+ T cells, helper T cells, immune breadth

3.

From Training to Activation: A Pass/Fail Framework for Deployable Outbreak Laboratories

Number of pages: 34 Posted: 01 Apr 2026
London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Université Catholique de Bukavu, Université Catholique de Bukavu, National Public Health Laboratory, National Public Health Laboratory, National Institute of Public Health, National Institute of Public Health, Coalition for Epidemic Preparedness Innovations, Coalition for Epidemic Preparedness Innovations, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Coalition for Epidemic Preparedness Innovations, University of Queensland - School of Chemistry and Molecular Biosciences and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 33 (1,277,121)

Abstract:

Loading...

Laboratory readiness, Outbreak readiness, Epidemic preparedness, Health systems strengthening, Deployability Framework, Infrastructure, Workforce competency, global health